Service Header - Due Diligence

Due Diligence & Business Development

BUSINESS DEVELOPMENT

Decision-making is the biggest risk taken by investors. In this context, MediTech Access aims to help healthcare innovators optimize their market value for their future projects (e.g. pricing and reimbursement) and partnerships, at a reasonable cost and controlled risk.

Business Dev - Wide Range of Actions

A WIDE RANGE OF ACTIONS

For optimized decision-making based on client needs

  • From small, medium and large pharmaceutical and medical device companies.
  • From European mapping to country-specific concerns.
  • Examples of support: convincing new investors, identifying the best clinical development scenario, program prioritization.
Business Dev - Value Assessment

COMPLETE BUSINESS VALUE ASSESSMENT

To best identify options for a product

Pricing and reimbursement potential assessment:

  • Review of baseline information including epidemiological data, disease severity and existing therapeutic/diagnostic alternatives.
  • Identification of national and international practice guidelines, unmet medical needs and level of available evidence.
  • Identification of the potential place of the innovation in the current strategy.
  • HTA stress test presentation and analysis.

Complete market overview:

  • Target population calculation (accounting for national specificities).
  • Competition analysis including prices, sales forecasts and market share estimates.
  • Understanding of decision-makers' needs and objectives on each market.
  • Identification of key value drivers that would accelerate market adoption.
Business Dev - Risk Assessment

A THOROUGH RISK ASSESSMENT

For optimized decision-making

  • Identification of strengths, weaknesses, opportunities and threats (SWOT) for each indication.
  • Analysis of price corridors and general pricing threats (competitor prices, price forecasts per country, based on HTA stress test or other sources).
  • Estimation of the level of risks and barriers to market entry. Identification of potential country-specific reimbursement issues.
  • Anticipation of the evolution of the clinical and competitive landscape, the reachable price and the chances of sustainable reimbursement.
Business Dev - Investor Support

DELIVERING KEY MESSAGES TO INVESTORS

To build the market access value of your products

Start-ups face many issues before their product launch and in particular fundraising. MediTech Access can help them build the market access value of their products.

  • Setup of a European mapping, with prioritization of the most relevant countries for market entry.
  • Establishment of a full market access roadmap (with action plan and timelines).
  • Providing full value proposition to optimize market access and targeted price.
  • Coaching (experience sharing, key messages presentation by MediTech Access).
  • Preparation and participation in investor and partnering meetings.

WE DO NOT END THERE.

SEE HOW WE CAN SUPPORT YOU.

Contact us
Strategy
Public Affairs
Pricing & Negotiations
Medical Writing
Training
Due Diligence & Business Development
Health Economics